⚡ Flash Summary
Otsuka Pakistan Limited’s annual report for the year ended June 30, 2025, reveals a turnaround in profitability, despite persistent macroeconomic challenges and aging machinery. Revenue grew by 19.5% to Rs. 3.78 billion, driven by a strategic focus on clinical nutrition sales. The company achieved a net profit of Rs. 27.88 million, a notable improvement from the prior year’s net loss of Rs. 4.76 million. However, the Board has recommended a “nil” dividend, prioritizing the repayment of a substantial foreign currency loan and ongoing capital expenditures for machinery overhauling.
Signal: HOLD ⏸️
Strength: 6/10
Sentiment: POSITIVE
Time Horizon: MEDIUM_TERM
📌 Key Takeaways
- 📈 Revenue increased by 19.5% from Rs. 3.16 billion to Rs. 3.78 billion, driven by Clinical Nutrition sales.
- ✅ The company achieved a net profit of Rs. 27.88 million, compared to a net loss of Rs. 4.76 million in the previous year.
- 💰 Finance costs decreased significantly from Rs. 102.81 million to Rs. 5.90 million due to surplus cash.
- ⚠️ Mark-to-market losses from a foreign currency loan continued to affect the bottom line due to currency depreciation.
- 💲 Earnings per share (EPS) improved to Rs. 2.29 from a negative Rs. 0.39.
- 🏭 The company faced production constraints due to aging machinery.
- 🔄 A strategic shift to a door-to-door distributor warehouse-based delivery approach improved operational efficiency.
- 💼 Selling and distribution expenses increased by 37.3% due to hiring new EN team and outward freight.
- 📜 The Board has proposed a “nil” dividend due to a large foreign currency loan and planned capital expenditures.
- 🗓️ The foreign currency loan of approximately PKR 1 billion has been extended and is now repayable in 2026.
- 🌱 Plans are underway to expand the product portfolio with new Enteral Nutrition (EN) products.
- 🔒 Robust safety measures were put in place to ensure the health, safety and wellbeing of employees.
- 🌐 The Company is an indirect subsidiary of Otsuka Pharmaceutical Company Limited, incorporated in Japan.
🎯 Investment Thesis
A HOLD recommendation is appropriate. Although Otsuka Pakistan has shown improvements in profitability, ongoing currency risks from the significant loan and no dividend in sight require caution. The company’s commitment to innovation and operational efficiency should result in long-term growth. The long wait on return from an existing investment warrants caution.
View Original PDF
Disclaimer: AI-generated analysis. Not financial advice.